These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29445831)

  • 1. Using a sequential explanatory mixed method to evaluate the therapeutic window of opportunity for initiating osteoporosis treatment following fragility fractures.
    Roux S; Gaboury I; Gionet-Landry N; Garant MP; Beaulieu MC; Carrier N; Cabana F; Boire G
    Osteoporos Int; 2018 Apr; 29(4):961-971. PubMed ID: 29445831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
    Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
    J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming primary care physicians to treat osteoporosis after a fragility fracture: an integrated multidisciplinary approach.
    Roux S; Beaulieu M; Beaulieu MC; Cabana F; Boire G
    J Rheumatol; 2013 May; 40(5):703-11. PubMed ID: 23504379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of treatment in Australian men following fracture.
    Otmar R; Henry MJ; Kotowicz MA; Nicholson GC; Korn S; Pasco JA
    Osteoporos Int; 2011 Jan; 22(1):249-54. PubMed ID: 20229198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study.
    Fraser LA; Ioannidis G; Adachi JD; Pickard L; Kaiser SM; Prior J; Brown JP; Hanley DA; Olszynski WP; Anastassiades T; Jamal S; Josse R; Goltzman D; Papaioannou A;
    Osteoporos Int; 2011 Mar; 22(3):789-96. PubMed ID: 20683706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-fracture care gap: a retrospective population-based analysis of Hong Kong from 2009 to 2012.
    Cheung MY; Ho AW; Wong SH
    Hong Kong Med J; 2018 Dec; 24(6):579-583. PubMed ID: 30449735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice Patterns and Performance in U.S. Fracture Liaison Programs: An Analysis of >32,000 Patients from the Own the Bone Program.
    Dirschl DR; Rustom H
    J Bone Joint Surg Am; 2018 Apr; 100(8):680-685. PubMed ID: 29664856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and Management of Osteoporotic Fractures: A Nation-wide Survey of 484 Senior Orthopaedists in China.
    Man Y; Pan W; Lu J; Li SY; Zhang P; Guo JZ; Yu SF; Zhang B; Xiao E; Zhang C; Zuo W; Jin HJ; Chen Y; Wu B; Shi XE; Hong D; Liu X; Gao YX; Li J; Yin L; Xue QY
    Orthop Surg; 2016 Nov; 8(4):432-439. PubMed ID: 28032704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
    Burge RT; Disch DP; Gelwicks S; Zhang X; Krege JH
    Osteoporos Int; 2017 Mar; 28(3):799-809. PubMed ID: 28028555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy's fracture clinic screening program.
    Beaton DE; Dyer S; Jiang D; Sujic R; Slater M; Sale JE; Bogoch ER;
    Osteoporos Int; 2014 Jan; 25(1):289-96. PubMed ID: 23794044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis in the Women's Health Initiative: Another Treatment Gap?
    Sattari M; Cauley JA; Garvan C; Johnson KC; LaMonte MJ; Li W; Limacher M; Manini T; Sarto GE; Sullivan SD; Wactawski-Wende J; Beyth RJ
    Am J Med; 2017 Aug; 130(8):937-948. PubMed ID: 28366425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic Fragility Fractures: An Opportunity to Improve the Undertreatment of Osteoporosis.
    Smith CT; Barton DW; Piple AS; Carmouche JJ
    J Bone Joint Surg Am; 2021 Feb; 103(3):213-218. PubMed ID: 33269895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment.
    Modi A; Tang J; Sen S; Díez-Pérez A
    Curr Med Res Opin; 2015 Apr; 31(4):767-77. PubMed ID: 25708648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary and Secondary Prevention of Hip Fragility Fracture in Teruel Health Sector, Aragon, Spain].
    Gómez Navarro R; González García P; Martín Hernández C; Castro Sauras Á; Valdearcos Enguídanos S
    Rev Esp Salud Publica; 2017 Jan; 91():. PubMed ID: 28025971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of coordinator-based osteoporosis intervention in fragility fracture patients: a prospective randomized trial.
    Osaki M; Okuda R; Saeki Y; Okano T; Tsuda K; Nakamura T; Morio Y; Nagashima H; Hagino H
    Osteoporos Int; 2021 Mar; 32(3):495-503. PubMed ID: 33483796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equal treatment: no evidence of gender inequity in osteoporosis management in a coordinator-based fragility fracture screening program.
    Ansari H; Beaton DE; Sujic R; Rotondi NK; Cullen JD; Slater M; Sale JEM; Jain R; Bogoch ER;
    Osteoporos Int; 2017 Dec; 28(12):3401-3406. PubMed ID: 28891035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of prescribing and adherence patterns of anti-osteoporotic medications post-admission for fragility type fracture in an urban teaching hospital and a rural teaching hospital in Ireland between 2005 and 2008.
    McGowan B; Bennett K; Casey MC; Doherty J; Silke C; Whelan B
    Ir J Med Sci; 2013 Dec; 182(4):601-8. PubMed ID: 23483361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fracture prevention service to bridge the osteoporosis care gap.
    Ruggiero C; Zampi E; Rinonapoli G; Baroni M; Serra R; Zengarini E; Baglioni G; Duranti G; Ercolani S; Conti F; Caraffa A; Mecocci P; Brandi ML
    Clin Interv Aging; 2015; 10():1035-42. PubMed ID: 26150707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden and undertreatment of fragility fractures among senior women.
    Rodrigues AM; Eusébio M; Santos MJ; Gouveia N; Tavares V; Coelho PS; Mendes JM; Branco JC; Canhão H
    Arch Osteoporos; 2018 Mar; 13(1):22. PubMed ID: 29516239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries.
    Yusuf AA; Matlon TJ; Grauer A; Barron R; Chandler D; Peng Y
    Arch Osteoporos; 2016 Dec; 11(1):31. PubMed ID: 27696099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.